A critical advance in cancer study is arising with the use of mini-antibodies to re-engage damaged p53. This crucial tumor inhibitor protein is frequently lost in several types of cancer, resulting uncontrolled tissue https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research